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Abstract Extensive research has been conducted on hydroxyapatite as a bone tis-
sue engineering scaffold due to its low toxicity, biocompatibility, bioactivity and
chemical similarity to bone. Hard coral species as well as red and green calcified
marine algae have naturally porous skeletons that resemble cancellous bone. Under
controlled hydrothermal conditions, these materials can be converted to hydroxya-
patite with their porosity and interconnectivity preserved. The availability of hard
coral species is limited due to the damage caused by harvesting procedures and
decline in coral reefs. As an alternative, hydroxyapatite can be produced from red
and green algae species. Currently, red algae derived Algipore® grafts are commer-
cially available for maxillary sinus bone augmentation. Long term clinical studies
have confirmed the bone regenerating capabilities of Algipore® when mixed with
autologous bone debris and blood, but research on the use of Algipore® tissue scaf-
folds seeded with mesenchymal stem cells is still ongoing. This chapter reviews
the synthesis of hydroxyapatite derived from marine algae and gives background
to clinical studies as well as the characterisation techniques used to analyse these
materials.
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Table 17.1 Biominerals produced by living organisms and their functions (Adapted from [3])
Mineral Formula Organism or
location
Function
Calcite CaCO3 Trilobite eyes Optical imaging
Aragonite CaCO3 Coral Exoskeleton
Amorphous calcium
carbonate
CaCO3·nH2O Plant leaves Calcium storage
Hydroxyapatite Ca-10(PO4)6(OH)2 Vertebrate bone Endoskeleton
Octacalcium
Phosphate
Ca8(HPO4)2(PO4)4·5H2O Vertebrate bone Precursor phase
Whewellite CaC2O4·H2O Plants Calcium storage
Barite BaSO4 Chara Gravity receptor
Celestite SrSO4 Acantharia Exoskeleton
Silica SiO2·nH2O Plant leaves Protection
Magnetite Fe3O4 Chiton teeth Grinding
Ferrihydrite 5Fe2O3·9H2O Animal ferritin Iron storage
17.1 Biomineralization
Biomineralization is the controlled process by which living organisms formminerals
[1, 2]. Biominerals are produced by species from all five living kingdoms, with over
60different biologicalminerals discovered [1].Among these, 50%of knownbiogenic
minerals contain calcium while 25% contain phosphate.
Biominerals provide a variety of functions for living organisms, including struc-
tural support, protection, motion, grinding, magnetic navigation and storage [3]
(Table 17.1). Depending on the application, each species produces unique mineral
structures with specific size, geometry, crystallinity and organisation [2, 4]. Biomin-
eralsmay also be classified as crystalline or amorphousmaterials. Crystalline biomin-
erals have ordered structures and morphologies which provide mechanical strength.
On the other hand, amorphous biominerals have the ability to fill spaces, and also
provide mechanical properties owing to the lack of fracture planes. In comparison to
crystalline minerals, amorphous materials have high solubility and low density [5].
The process of biomineralization may be divided into two categories. The first
category is biologically induced mineralization, where the precipitation of minerals
is induced in an open environment on the surface of cells with minimal biological
control [1, 2, 6]. As a result, biologically induced minerals are polycrystalline with
irregular orientations. Furthermore, the precipitatedmineral depends on the chemical
conditions of the external environment, leading to the heterogeneity of the mineral
between organisms of the same species [1, 2]. Examples of organisms that possess
this ability include monerans, fungi and green algae [1, 6].
The second category is biologically controlled mineralization. This process is
controlled genetically, producing crystalline minerals with ordered geometry and
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shape [6]. In contrast to biologically induced mineralization, mineral precipitation
occurs in a closed space and is mediated by an organic matrix [1]. The organic matrix
is composed of macromolecules such as proteins, polysaccharides and acidic glyco-
proteins [1, 2], which provide a three-dimensional (3D) framework for the nucleation
and growth of biominerals. The resulting biomineral is a composite material com-
prised of organic and mineral components with unique mechanical properties [2,
4]. Biologically controlled mineralization is used to produce mineralized tissue in
animals such as bone, teeth and shells [1].
17.2 Bone
Bone is a hard mineralized tissue found in animals. It serves a variety of functions
in the body such as structural support, movement, protection of organs, accommo-
dation of bone marrow and as a mineral reserve for homeostasis [7–9]. Bone is a
composite material with a predominately flexible Type 1 collagen organic matrix and
a substituted hydroxyapatite mineral phase [9]. As a result of the composite nature,
bone has excellent mechanical properties where the collagen provides elasticity, and
the mineral provides strength [8].
17.2.1 Mineral Phase
The first X-ray diffraction studies of bone conducted by de Jong revealed that the
mineral was an apatite-like material [10]. The mineral phase is nowwidely described
as hydroxyapatite (HAp; Ca10(PO4)6(OH)2) [8, 9]. Stoichiometric HAp has a hexag-
onal unit cell structure, with a calcium phosphate ratio of 1.67 [11, 12] (Tables 17.2
and 17.3).
However, further studies have shown that biogenic HAp minerals are non-
stoichiometric and are often substituted with other ions [15, 16]. LeGeros et al.
described the mineral as a carbonate-substituted apatite, where carbonate (CO32−)
ions displace hydroxide (OH−) or phosphate (PO43−) ions [15]. Carbonate substi-
tution is not only common in bone, but is characteristic of all biogenic apatites [12,
17]. Further substitution within the crystal lattice can occur with magnesium (Mg2+)
and acid phosphate groups (HPO42−) [8]. Therefore, the biogenic mineral in bone
can be described as a non-stoichiometric carbonate-substituted apatite.
In bone, carbonated HAp crystals have a uniform, thin, plate-like morphology
[12]. These crystals are small with an average length of 50 nm and width of 25 nm
[1, 8, 12]. As a consequence, they are poorly crystalline with higher solubilities
compared to other biogenic apatite minerals such as tooth enamel [8, 16].
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Table 17.2 Calcium phosphate compounds with their chemical formula and Ca/P ratio (adapted
from [13, 14])





Dicalcium phosphate dihydrate CaHPO4·2H2O 1.0 2.0–6.0
Amorphous calcium phosphate CaxHy(PO4)z nH2O (n = 3–4.5) 1.2–2.2 5.0–12
Octacalcium phosphate Ca8(HPO4)2(PO4)4·5H2O 1.33 5.5–7.0
α-Tricalcium phosphate (α-TCP) α-Ca3(PO4)2 1.5 –




(0 < x < 1)
1.5–1.67 6.5–9.5
Hydroxyapatite (HAp) Ca10(PO4)6(OH)2 1.67 9.5–12
Tetracalcium phosphate Ca4(PO4)2O 2.0 –
Table 17.3 Selected crystal classes of calcified systems
Crystal class Unit cell dimensions Example
Hexagonal a = b = c; α = β = 90° γ = 120° Hydroxyapatite
Orthorhombic a = b = c; α = β = γ = 90° Aragonite
Trigonal a = b = c; α = β = γ = 90° Calcite
17.2.2 Organic Phase
Theorganicmatrix is primarily composed ofType 1 collagen (85–90%), in addition to
collagenous proteins such as proteoglycans, and non-collagenous proteins including
osteocalcin and osteonectin [7, 8, 12, 18].
To form collagen fibrils, three polypeptide chains arrange into a triple helix that
is 80–100 nm in diameter [12, 18]. They provide a 3D matrix on which HAp crystals
nucleate and grow. The crystals are embedded across and between collagen fibrils
in organised layers, forming a composite material [12]. Following crystal formation,
the mineralized collagen fibrils align together in bundles to produce collagen fibres
that subsequently bind to one other through an organic phase and form a fibril array
[12, 18].
17.2.3 Bone Architecture
The two types of bone tissue are cortical and cancellous bone. Cortical bone is the
dense, compact outer wall of bone while cancellous bone is the spongy structure
found at the ends and centre of long bone as well as the middle of vertebrae [7, 9].
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Cortical bone provides mechanical strength, and contains pores that range from
100 nm to 50μm[9, 19]. It is composed of organised arrays of cylindricalmineralized
structures called osteons [8, 12]. Each osteon is constructed by concentric cylindrical
layers, called concentric lamellae. The concentric lamellae enclose a narrow channel
in the centre called the central canal that accommodates blood vessels and nerves
[9]. Transverse canals are located between adjacent osteons to connect the central
canals. Other microscopic features that form pores include capillary channels called
canaliculi, and small spaces between the concentric layers called lacunae which
house osteocyte bone cells [12].
In contrast, cancellous bone is highly porous with poor mechanical strength [9].
Cancellous bone is formed by a network of interconnecting beams called trabeculae
[7, 9]. The pores within trabeculae range from 200 to 600 μm, and are used to
accommodate cellular structures and bone marrow [9, 19].
17.2.4 Bone Remodelling
Bone is a regenerative tissue that undergoes continuous remodelling throughout a
person’s lifespan [8]. Bone remodelling is the process in which old bone tissue is
removed and replaced by new, regenerated bone. The three bone cells involved are
osteoclasts, osteoblasts and osteocytes.
Remodelling beginswith the resorption of old bone tissue byosteoclast cells [7–9].
Osteoclast cells secrete hydrogen ions and enzymes to digest the mineral and organic
matrix, resulting in the formationof cavities. Following this, bone forming cells called
osteoblasts produce a new organic matrix by synthesising collagen molecules and
non-collagenous proteins. Osteoblast cells mediate HAp mineralization, leading to
the formation of new bone tissue. Osteoblasts cease bone formation once entrapped
within the mineralized tissue, and are then termed osteocyte cells [9, 20].
Bone remodelling is an important process, as it preserves the mechanical strength
of bone. Ageing and physical activity result in the formation of microfractures in
bone, leading to a decline in mechanical strength [8]. By replacing older bone tissue
with newly regenerated bone, the quality of bone, as well as calcium homeostasis is
maintained.
17.2.5 Bone Grafts
A unique characteristic of bone is its ability to repair and regenerate when damaged
[21].Despite this, permanent damageof bonemayoccur due to large trauma fractures,
infections or tumour resections [21, 22]. In addition, the density and regenerative
ability of bone decrease with age. The condition where cancellous bone thins out and
increases bone fragility is called osteoporosis [7]. In 2000, an estimate of 9.0 million
fractures occurred worldwide as a consequence of osteoporosis [23]. Osteoporotic
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fractures can cause morbidity and disability, and are expected to increase drastically
as the population ages [7, 23].
Surgical procedures are required to aid regeneration when bone fails to repair. To
treat defects, bone grafts are typically implanted. Bone grafts are the second most
common transplant procedure, with over 2.2 million surgeries performed annually
worldwide [21]. Ideal graft materials are biocompatible, osteogenic, osteoinductive
and osteoconductive. These characteristics are defined by Keating and McQueen
[24] and Williams [25] as:
• Biocompatibility: the ability of a biomaterial to perform the desired function in
medical therapy by generating a cellular or tissue response without causing unde-
sirable effects.
• Osteogenic: the capacity of a material to regenerate new bone through osteocytes
and osteoblasts cells.
• Osteoinductive: stimulation of bone regeneration by inducing the differentiation
of osteoblast cells from mesenchymal stem cells (MSCs).
• Osteoconductive: the capacity of a material to provide an inert scaffold for bone
ingrowth and subsequently, regeneration.
Bone grafts are traditionally harvested from the pelvic crest of the patient’s or
donor’s tissue [26]. These are known as autologous and allogenic grafts, respectively.
Autologous grafts are referred to as the “golden standard” due to their biocompatible,
osteogenic, osteoinductive and osteoconductive properties [24, 27]. Although clini-
cally successful, they present issues such as persistent pain, morbidity, limit of supply
and the cost of surgical procedures and recovery [26, 27]. In comparison, allogenic
grafts are biocompatible, osteoinductive and osteoconductive but lack osteogenic
properties. The disadvantages of allogenic bone grafts are similar to those of their
autologous counterparts, with the additional risk of disease transmission [26, 27].
For these reasons, it is important to develop substitute materials to be used in place
of these grafts.
17.2.6 Bone Substitute Materials
Biomaterials are defined by Williams as substances that have been engineered to
direct or interact with components of a living system for any therapeutic or diagnos-
tic procedure [28]. The primary purpose of a biomaterial is to restore the functions of
a living organ or tissue to improve the quality of human health [29]. Example appli-
cations include artificial joints, dental implants, artificial heart valves and contact
lenses [30]. For biomaterials to be successful in restoring physiological functions,
they must be biocompatible, pharmacologically acceptable, and have appropriate
mechanical properties and design that are suitable for its application [29].
A wide variety of materials can be used to construct implants. Currently, the four
classes of synthetic materials used for biomedical applications are metals, polymers,
ceramics and composites [29, 30] (Table 17.4).
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Upon implantation, there are four ways biomaterials can react with surrounding
tissue [31]:
• Biotoxic: pathological change or rejection by surrounding tissue;
• Bioinert: coexistence between material and tissue with minimal change;
• Bioactive: biochemical adhesion between material and tissue; and
• Bioresorbable: gradual dissolution and displacement of material by new tissue.
Among the four classes of biomaterials, ceramics have the potential to be used
as orthopaedic implants and grafts due to their bioactive and bioresorbable proper-
ties [29]. Calcium sulphate and calcium phosphate materials are two examples of
bioceramics that have been successfully used as bone grafts [27]. However, a major
disadvantage of ceramics is that they are brittle with poor mechanical strength [26,
29, 31]. To compensate, ceramics can be manufactured as composites or coatings
[31], but further developments are required to improve the overall design of ceramic
implants.
17.2.7 Bone Tissue Engineering
Tissue engineering is an emerging field of research that aims to develop biological
substitute materials to restore, maintain or improve tissue function using living cells
[32, 33]. Unlike traditional biomaterials, a tissue engineering implant has a living
function that helps to restore the biological function of the replaced tissue or organ
[34].
The two fundamental components of a tissue engineering implant are the living
cells and the extracellular matrix [33, 35]. The cells used may be either autologous or
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allogenic, and are specific to the organor tissue being replaced [35]. In particular, stem
cells have been used extensively in this field as they can be differentiated into a desired
type of cell such as bone or cartilage. Growth factors can also be supplied to support
the growth and differentiation of stem cells [33]. The extracellular matrix provides
a scaffold that accommodates the cells as well as the 3D structure of the tissue in
which the cells are grown and proliferated [33, 35]. The scaffold may be produced
using natural materials such as starch [36] or chitosan [37], or synthetic materials
such as calcium phosphate bioceramics [38] or polymers such as polyglycolic acid
[39] depending on the application.
In the application of bone tissue engineering, the scaffold should ideally mimic
the natural structure of bone [34]. Additionally, it must be biocompatible, osteocon-
ductive, osteoinductive and bioresorbable to allow the formation of new bone tissue
at the implanted site [34, 40, 41]. Another property of the scaffold that is crucial for
bone tissue engineering is its porosity. Scaffoldsmust contain a large volume of inter-
connected pores to allow the ingrowth of bone cells, tissue and blood vessels. Rough
surface structures can also promote osteoconduction by supporting the attachment
and proliferation of bone cells. Scaffolds are required to have sufficient mechanical
properties that are similar to the surrounding bone tissue at the implanted site.
Following the development of a scaffold, the appropriate cell must be selected
and cultured. The two that are commonly chosen for bone tissue engineering are
osteoblast cells or stem cells [34, 40]. Osteoblast cells are involved in the process of
bone regeneration, and may be isolated and grown from the patient’s own bone tissue
to reduce the possibility of a negative immune response [42]. However, according
to Salgado et al. [34], there are a limited number of osteoblast cells available in
the patient’s tissue and the process involved to isolate and proliferate these cells is
slow. Alternatively, they suggest the use of stem cells as they are readily available
in the patient’s tissue and have high ability to differentiate. Among the different
types of stem cells, MSCs are gaining popularity in bone tissue engineering as they
are available within bone marrow and demonstrate osteogenic characteristics [34,
43, 44]. In 1998, Bruder et al. first isolated and cultured human MSCs and loaded
them into a ceramic scaffold to demonstrate their potential to heal bone defects
[45]. Bone regeneration was observed within four weeks of implantation, and new
bone tissue was found within the porous ceramic at the end of the 12 week study.
Through this, Bruder et al. were able to demonstrate that humanMSCs were capable
of differentiating into osteoblast cells which form new bone tissue within the ceramic
implant. Although research into the use of MSCs for tissue engineering is ongoing
they show promising potential in the application of bone regeneration.
Another addition that can be made to a tissue engineering implant are growth
factors [46]. In bone tissue engineering, growth factors play an important role in the
adhesion and proliferation of cells within the scaffold. They are secreted by cells in
the form of cytokines and are involved in cell signalling and communication [46].
Some examples of growth factors that have been used in bone tissue engineering
include the osteoinductive bone morphogenetic proteins [47], osteogenic fibroblast
growth factors [48] and platelet derived growth factors [49]. Growth factors may be
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added to help enhance bone regeneration and improve the osteogenic properties of
tissue engineering implants.
17.3 Calcium Phosphate Bioceramics
HAp-based bioceramics are of particular interest due to their chemical similarity to
the mineral in bone [8, 17, 31, 50]. HAp materials are non-toxic, biocompatible and
bioactive, allowing them to attach and adhere to surrounding bone upon implantation
[13, 27, 50]. Furthermore, they are osteoconductive, providing a scaffold in which
bone cells can integrate to enable the formation of new bone tissue [51, 52]. These
characteristics allow synthetic HAp to be applied as a substitute bone graft material.
HAp is part of a collective group of related phases known as calcium phosphate
compounds (Table 17.2). These compounds consist of calcium, phosphorous and
oxygen atoms arranged in amorphous or crystalline structures [13]. Each compound
has a characteristic calcium to phosphorous molar ratio (Ca/P), pH solubility and
crystallinity (Table 17.2) [13, 53].
Calciumphosphate compounds are bioresorbable to different degrees and undergo
dissolution after implantation, resulting in the formation of HAp in new bone tis-
sue [31]. The rate of dissolution of the compounds decreases as the Ca/P ratio
increases [31, 50, 52]. Compounds with Ca/P molar ratios greater than 1 are ideal
for orthopaedic applications, as fast dissolution rates may lead to destructive effects
[54, 55].
Although calcium phosphate bioceramics lack osteoinductive properties, the
structure of the ceramicsmay bemanipulated to induce the regeneration of bone.Ani-
mal studies conducted by Yuan et al. demonstrated the osteoinductive properties of
microporous HAp implants compared to HAp implants without pores [55]. Accord-
ing to LeGeros [19], micro- and macropores in calcium phosphate implant materials
entrap bioactive proteins that promote osteoinduction. Additionally, porous implant
materials mimic the microstructure of bone, stimulating attachment, tissue ingrowth
and vascular integration [13, 19, 52]. Overall, these studies provide evidence that the
design of HAp bioceramics play a major role in the biological response.
17.3.1 Synthesis Methods
A variety of methods for the synthesis of HAp and other calcium phosphate mate-
rials have been developed (Table 17.5). These methods produce HAp with different
crystallinity, geometry, and size [54]. For wet chemical procedures such as chem-
ical precipitation, hydrothermal, sol-gel and hydrolysis methods, control over the
pH, temperature and concentration of reagents are necessary to synthesise HAp of
desired physical and mechanical properties [56, 57]. Wet chemical procedures have
been well characterised and optimised by a number of researchers [56–60].
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A challenge associated with the synthesis of HAp for bone replacement applica-
tions is the incorporation of pores that mimic the microarchitecture of bone. Porous
HAp structures have large surface areas that enhance the bioactivity and osteoinduc-
tivity of the material, and allow the incorporation of bone cells and blood vessels
[19, 61]. Various values have been suggested for the optimum pore size, which range
between 10 and 500 μm [62, 63]. However, the addition of pores decreases the
mechanical strength of ceramics, creating further challenges [61].
A common procedure employed to produce porous ceramics is the incorpora-
tion of volatile additives, known as porogens. Porogens such as polyvinyl butyral
leave pores within the materials when sintered of uniform size [73]. However, a
major limitation of their use is the random distribution of pores and their lack of
interconnectivity. An alternative technique called gel cast foaming produces ceram-
ics with high mechanical strength, but the method can be complicated and result
in a large pore size distribution and lack of pore interconnectivity [61, 74]. The
polymer sponge method or combination procedures are additional techniques that
produce porous HAp ceramics with high porosity and interconnectivity [61, 75]. In
these processes, a polymer template is utilised, allowing the controlled production of
porous structures [75]. However, the method is relatively complicated and involves
long procedures.
Table 17.5 Synthesis methods used to produce HAp
Method Reagents Reference(s)
Chemical Precipitation Ca(OH)2 and H3PO4 or
(NH4)2HPO4
Santos et al. [59]
Ca(NO3)2·4H2O and
(NH4)2HPO4
Mobasherpour et al. [64]
CaCl2·2H2O and Na2HPO4 Mekmene et al. [57]
Hydrothermal Ca(OH)2 and CaHPO4·2H2O Liu et al. [56]
Ca(NO3)2·4H2O and
(NH4)2HPO4
Earl et al. [60]
Sol–Gel Ca(C2H3O2)2 and PO(OC2H5)3 Jillavenkatesa and Condrate [58]
Hydrolysis DCPD (CaHPO4·2H2O) and
CaCO3
Shih et al. [65]
Solid State Ca(OH)2 and Ca3(PO4)2 Rao et al. [66]
Mechano-chemical CaO and CaHPO4 Yeon et al. [67]
Combustion Ca(NO3)2·4H2O and
(NH4)2HPO4









Vecchio et al. [71]
Egg shells (CaCO3) and
(NH4)2HPO4
Raihana et al. [72]
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In recent studies, HAp scaffolds have been produced using 3Dprinting technology
[76–78]. The scaffold is designed using computer software, printed by depositing
HAp granules layer by layer then sintered to produce the final structure. 3D printing
is advantageous as implants may be customised for each patient [77]. Additionally, it
allows the controlled manufacture of complex, porous structures with high precision
and resolution. For example, Fierz et al. [77] designed scaffolds with longitudinal
channels and interconnecting pores to encourage vascularisation of implants and
improve osteoconduction. Although 3D printed HAp scaffolds are typically cylin-
drical to improve their loading capacities, material testing conducted by Cox et al.
demonstrated their poor mechanical strength [78]. With further development, 3D
printed ceramics of complex structures may be used to aid bone regeneration.
17.3.2 Synthesis from Biogenically Derived Minerals
In previously discussedmethods, HAp is initially synthesised as powders or granules
before being moulded or shaped into a porous ceramic. An alternative approach to
produce porous HAp materials is to convert porous calcified structures derived from
living organisms.
Calcium carbonate (CaCO3) biominerals are found inmanymarine organisms and
egg shells as exoskeletons or endoskeletons [3, 79]. The porous microarchitecture of
these natural materials closely resembles the microarchitecture of bone, which can
be preserved when converted to HAp under controlled experimental conditions [69,
70]. These pores promote the ingrowth of bone cells and tissue that subsequently
leads to the regeneration of bone. Furthermore, HAp derived from biogenic sources
exhibits physiochemical similarity with bone, improving biocompatibility [79].
Several examples of biogenically derived mineralized structures or organisms
that have been converted to HAp include egg shells [72] cuttlefish bone [80], starfish
[81], seashells [71], coral [69, 70, 82] and red algae [14, 83, 84] (Fig. 17.1). Among
these, extensive research has been performed on coral as a precursor material. It is
important to note that the organic or cellular material must be removed using thermal
or chemical treatment before the mineralized structure is converted to HAp in order
to avoid biotoxic rejection of implant material.
17.3.2.1 Coral
Coral is a marine organism distributed in tropical regions in shallow waters. Corals
are built up from colonies of individual animals called polyps that form an inorganic
skeleton [85]. The mineral component of the biomineralized skeleton is the CaCO3
polymorph aragonite which has an orthorhombic unit cell structure. In comparison,
calcite is the thermodynamically stable CaCO3 polymorph which has a trigonal unit
cell structure (Table 17.3). Although calcite is stable at standard temperature and
louise.evans@uts.edu.au
394 G. Choi and L. A. Evans
Fig. 17.1 Schematic diagram showing synthesis of porous or powdered HAp bioceramics derived
frommarine exoskeletons. Step one is the removal of organic material and step two is the conversion
of calcium carbonate biominerals to HAp
pressure, many marine organisms produce aragonite due to the high ionic strength
of sea water [86].
Coral has a unique structure that is highly porous.Many species of hard coral have
interconnecting porous networks that are almost identical to the microarchitecture of
bone [87]. The use of coral as a rawmaterial for the synthesis of porous HApwas first
demonstrated by Roy and Linnehan [69]. These authors developed a method for the
hydrothermal exchange of CaCO3 from the coralPorites’ skeletonwith diammonium
hydrogenphosphate ((NH4)2HPO4) solution to produceHAp.The reaction tookplace
in a sealed gold tube heated at 270 °C with a pressure of 103 MPa over 24 h. The
equation below describes the hydrothermal exchange:
10CaCO3 + 6(NH4)2HPO4 + 2H2O → Ca10(PO4)6(OH)2 + 6(NH4)2CO3 + 4H2CO3
According to Roy and Linnehan [69], the high temperatures and pressures used
in hydrothermal conversion accelerate the process of ion exchange and sterilise the
product. The interconnecting porous structure of coral was successfully preserved
after conversion, showing its potential use as an implant material. However, further
development of reaction conditions was required, as the pressure and temperatures
reported by the authors were extremely high.
Later, Sivakumar et al. further developed amethod to convert CaCO3 derived from
Indian Goniopora coral [82]. Goniopora species have interconnecting pores that
closely resemble cancellous bone. The coral was initially cleaned and subjected to
heat treatment at 900 °C for 2 h to remove organic matter and impurities. Afterwards,
the heat treated coral was placed in a pressure vessel with (NH4)2HPO4 solution
at elevated pressures for several hours. The final product was termed “coralline
hydroxyapatite”. Although heat treatment allowed the removal of impurities and the
organic phase, the primary limitation of thismethod is the transformation of aragonite
into brittle calcium oxide (CaO) during thermal treatment at elevated temperatures.
As a result, the final coralline HAp produced by Sivakumar et al. was powdered, and
could not be used as an implantwithout further processing. In addition, the conditions
used for hydrothermal conversion were not specified.
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Fig. 17.2 Diagram of the hydrothermal apparatus typically used to convert aragonitic coral to HAp.
The sealed Parr reactor is subjected to a high temperature which increases the pressure within the
reactor. As a result, phosphate ions from the solution exchange with carbonate ions in the coral
structure to produce HAp
Further method development using Australian Goniopora coral was reported by
Hu et al. [70]. These authors used boilingwater and 5%sodiumhypochlorite (NaOCl)
solution to remove the organic matter chemically instead of using the thermal treat-
ment procedure reported by Sivakumar et al. A Parr reactor with a Teflon liner was
used to convert aragonite to HAp (Fig. 17.2). The reaction took place at 250 °C at a
pressure of 3.8 MPa with excess (NH4)2HPO4 over 36 h. Hu et al. successfully pro-
duced carbonate substituted coralline HAp that retained the interconnecting porous
structure of coral (Fig. 17.3). Note that the pressure used was lower relative to that
of Roy and Linnehan’s method given above. The pore size of coralline HAp was
reported as 200–250 μm, which is ideal for tissue ingrowth.
Although hydrothermal conversion has been used successfully to produce porous
HAp of high crystallinity, these methods involve high pressures and temperatures.
Furthermore, these processes are costly due to the complexity of the reaction vessels
and conditions required.
An alternative method to produce biphasic CaP and CaCO3 composite scaffolds
from coral using microwave processing was developed by Pena et al. [88]. In their
procedure, a domesticmicrowavewas utilised at different powers over a period of 5 h.
Microwave processing allows the uniform heating of particles, removal of volatile
compounds and reduction in thermal stress, resulting in the preservation of the porous
microarchitecture [88]. As a result, chemical or thermal treatments are not required
for the removal of the organic component. Although pure HAp was not produced,
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Fig. 17.3 SEM micrographs of Australian Goniopora coral. a Prior to conversion; and b after
hydrothermal conversion demonstrating the preservation of interconnecting pores (adapted from
[70])
the composite mixture of CaCO3 and CaP was shown to improve the resorption and
bioactivity of the porous scaffold.
Mechano-chemical methods provide another alternative in preparing coralline
HAp. This procedure was used by Cegla et al. [89] and Macha et al. [90] for the
conversion ofAustralian coral. To prepare corallineHAp, coral sampleswere cleaned
using 2% NaOCl and ground with an aluminium ball mill. Afterwards, the coral
powder was suspended in 150 mL distilled water on a heated magnetic stirrer plate at
200 rpm and 80 °C. Phosphoric acid (H3PO4) or ammonium dihydrogen phosphate
(NH4H2PO4) was added to the suspension drop wise, and the reaction was left for
24 h.
In both studies, the effect of pH on the final product was examined. According
to Cegla et al. CaCO3 dissolves in H3PO4 due to the acidic conditions, resulting in
the precipitation of calcium phosphate once supersaturation has been achieved [89].
Furthermore, the primaryphase formedwas found tobemonetite,withHApproduced
as aminor phase. Results presented by Pena et al. under varied pH conditions support
these observations [88]. However, under basic conditions, CaCO3 does not dissolve,
and HAp is produced through ion exchange. Owing to this, Cegla et al. suggested
treatment of coral at high pH conditions to allow the preservation of its unique
microarchitecture.
Mechano-chemical methods provide an inexpensive, simple procedure in the pro-
duction of coralline HAp in comparison to hydrothermal conversion [89]. As low
temperature and pressure conditions are used, the reaction can bemonitored over time
by taking aliquots, which cannot be reproduced in hydrothermal methods. Despite
this, mechano-chemical methods have only been applied to coral powders, so it is
unknown if the procedure could also be applied to 3D coral structures.
louise.evans@uts.edu.au
17 Calcified Algae for Tissue Engineering 397
Coralline HAp is an excellent bone tissue engineering scaffold because of its
characteristic porosity and chemical similarity to bone. Coral species such as Porites
andGoniopora are composed of 99% aragonite and can be sliced to the desired shape
before conversion [91]. However, a significant limitation regarding the use of coral
for biomedical applications is the lack of supply and damaging effects of harvesting
procedures [87]. Coral reefs are declining on a worldwide scale due to warming sea
waters, overfishing and ocean acidification, with over 20% of reefs destroyed as of
2004 [92]. As coral plays a significant role in marine ecosystems, preservation and
conservation are crucial for the environment.
17.3.2.2 Calcified Macroalgae
Algae are a group of plant-like organisms that come in diverse sizes and environments
[93]. Certain species of freshwater and marine algae deposit CaCO3 along their cell
walls, forming a calcified skeleton that provides mechanical support and protection
[86, 93]. With the exception of some red algae species, marine algae produce CaCO3
as the polymorph aragonite [86].
Calcified macroalgae may be used as an additional source of biogenic CaCO3
because of their porous skeletons. Similar to coral, calcified algae contain intercon-
nectingmicropores that allow the transport of nutrients between cells [94]. According
to Felício-Fernandes and Laranjeira, harvesting algae will not cause extensive dam-
age to surrounding seabeds such as coral [14]. Furthermore, they are easy to maintain
and are widely available.
The first study on algae-derived HAp was conducted by Kasperk and Ewers [83].
In their study, the red algae species Corallina officinalis was converted to HAp and
compared with coralline derivatives [94]. Kasperk et al. found that C. officinalis
species contained longitudinal micropores that were 10 μm wide and 30 μm long
which formed a honeycomb pattern on the surface. As a result of these micropores,
the surface area of the algaewas found to be greater than corallineHAp. Furthermore,
they reported that the small crystal size of algae-derived HAp further improved the
osteogenesis of the implant compared to coralline HAp. This algae-derived HAp is
commercially available under the product name Algipore® [95].
Later, Felício-Fernandes and Laranjeira developed a hydrothermal method for
the conversion of CaCO3 from the red algae Rodophycophyta [14]. These algae
have a unique porosity and contain a high amount of CaCO3 as the polymorph
calcite [86]. The red algae were initially washed with water and 10% NaOCl to
remove the organic matter. Afterwards, hydrothermal conversion was achieved in
a sealed reaction vessel with a stoichiometric amount of (NH2)4HPO4 at 200 °C
for a period of 24–48 h. The final product was characterised as non-stoichiometric
carbonated HAp. Although pure HAp was not synthesised, Felício-Fernandes and
Laranjeira argue that the chemical similarity between algae-derived HAp and bone
is advantageous. Furthermore, scanning electron microscopy (SEM) revealed the
interconnecting pores which were preserved after the conversion of the algae, similar
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to the work of Kasperk and Ewers [83]. The average pore diameter was reported as
20 μm.
Another method reported by Walsh et al. produced HAp derived from red coral
species C. officinalis using a low temperature hydrothermal conversion [84]. The
mineral phase of C. officinalis is a magnesium-rich calcite. To remove magnesium
and organic matter, the algae were first washed and subjected to heat treatment to
700 °C with a slow ramp of 0.5 °C/min to prevent structural decomposition. To
synthesise HAp, stoichiometric NH4H2PO4 solution was mixed with the algae in
a reaction flask stirred at 100 rpm at a temperature of 100 °C for 12 h. In this
procedure, the porous microstructure of the algae was preserved after conversion.
One major drawback of this approach is the thermal decomposition of CaCO3 into
brittle CaO when pre-treated at 700 °C as CaO produces HAp with poor mechanical
properties. Also, the pores had an average diameter of 10μm and formed long canals
that lacked interconnectivity. Regardless of these issues, the conversion procedure
is simple compared to the one reported by Felício-Fernandes and Laranjeira [14], as
it utilises equipment that is readily available, and allows hydrothermal synthesis at
atmospheric pressure and low temperatures. However, pre-treatment to remove the
organics at a lower temperature would be preferable.
In a recent study, the green calcified algae Halimeda cylindracea was converted
to HAp [96]. Halimeda species are one of the most heavily calcified algae that are
abundant in tropical regions and coral reefs [86, 97]. The structure of these species
is described as an expanded, branched thallus of calcified segments that are joined
by a network of flexible organic fibres [93, 97] (Fig. 17.4). The mineralized skeleton
is composed of the CaCO3 polymorph aragonite [98] that is porous in structure,
allowing it to be a suitable precursor for the synthesis of porous HAp scaffolds.
H. cylindracea was initially treated using 2% NaOCl solution to remove the
organic material and impurities from the ocean. To convert the CaCO3 skeleton to
HAp, the hydrothermal method of Hu et al. [70] was followed over a slightly lower
temperature and time (220 °C over 24 h, lowered to 160 °C overnight). Chemical
characterisation confirmed the successful conversion of aragonite to HAp. In addi-
tion, SEMmicrographs revealed the porous surface of clean H. cylindracea that was
preserved after conversion with the removal of the plate-like coverings (Fig. 17.5a,
c). These pores were 7–18 μm in diameter, which is similar to the values reported
for red algae species [14, 84, 94]. Unpublished SEM micrographs demonstrated
that chemical treatment was insufficient in removing the fibrous organic material
that ran throughout the centre channel of H. cylindracea (Fig. 17.5b). However,
the high temperature and pressure conditions used during the conversion procedure
resulted in their removal (Fig. 17.5d). Cross sectional SEM micrographs reveal the
interconnected microporous channels that run throughout the mineralized skeleton
from the outer surface towards the inner cortex that were preserved after conversion
(Fig. 17.5d, f). The diameters of the channels increase as they merge towards the
inner cortex. Further work should be undertaken to characterise the physical, chem-
ical and mechanical properties of H. cylindracea derived HAp as results so far are
promising for orthopaedic applications.
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Various authors have demonstrated that CaCO3 derived from calcified red and
green algae can be converted through different methods to produce porous HAp
scaffolds.Algae-derivedHApcanprovide an alternative implantmaterial tominimise
the extensive damage caused by harvesting coral. However, a limitation of red algae is
its porosity. The average pore diameter for red algae reported by various authors range
from 10 to 20 μm [14, 84, 94], while pore diameters for Australian Goniopora coral
were reported as 200 to 250 μm [70]. Though the microporosity of algae promotes
the attachment of bone cells and tissue, the macroporosity of coralline HAp is similar
in dimension to cancellous bone, allowing the ingrowth of bone tissue [79, 94].
17.4 Clinical Studies on Algae-Derived HAp for Bone
Tissue Engineering
The first histological study conducted by Kasperk et al. [94] demonstrated the
osteogenic properties of C. officinalis algae-derived HAp under implantation in a rat
femur defect. In comparison to coralline derivatives, bone regeneration and vascular-
isation occurred more prominently in the algae-derived HAp. The authors suggested
that the interconnectedmicroporous architecture of the algae provided a large surface
area (50 m2 g−1) that allows for attachment of osteoblast cells which promote bone
regeneration. Furthermore, HAp crystals within the converted algae were small in
size and were chemically similar to the mineral in bone which may have favoured
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Fig. 17.5 SEM micrographs of green algae H. cylindracea a surface after cleaning; b longitudi-
nal cross-section after cleaning; c surface after conversion; d and e transverse cross-section after
conversion, and f inner surface after conversion
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bone regeneration upon implantation. It is now available commercially under the
name Algipore®, and is commonly utilised to reconstruct the maxillary sinus before
dental implant surgery. This procedure is conducted to ensure that there is sufficient
bone height and volume to surgically create sockets that secure dental implants [99].
In 1999, Schopper et al. conducted the first clinical trial on Algipore® for maxil-
lary sinus bone augmentation on 70 patients [100]. Before implantation, Algipore®
was mixed with bone debris (1:5–1:10 ratio) and venous blood obtained from the
patient during surgical procedures to provide the osteoinductive proteins and growth
factors that aid in bone regeneration. This method eliminated the need to harvest
autologous bone from the patient, reducing donor site morbidity and pain. After
6months of implantation, histological evaluation revealed the formation of new bone
tissue and partial resorption of Algipore® at the implanted site. Osteoblast cells and
unarranged collagen fibrils were also found in this region which are indicative of
formation of new bone tissue. Bone tissue and vascular ingrowth were also observed
within the porous structure of the material. A later clinical trial conducted by Ewers
et al. on a single patient showed similar results [101].
In a recent study, Poeschl et al. evaluated the effects of the addition of platelet-
rich plasma (PRP) in Algipore® implants for bone regeneration [102]. PRP can be
extracted from the patient’s own blood and contain a high concentration of platelets
andproteins. It provides an autologous source of platelet derivedgrowth factorswhich
enhance vascularisation and bone regeneration [102–104]. In Poeschl’s study, the
method reported by Schopper [100] was followed for a control group of 11 patients.
In a test group consisting of 14 patients, PRPs were processed from autologous
blood and were added to the Algipore®/bone debris mixture (1:10 ratio) in place
of venous blood. After 6–9 months of healing, histological and histomorphometric
results showed an increase in the formation of new bone with the addition of PRP
to Algipore® and bone debris indicating positive effects. However, an animal study
conducted by Klognoi et al. [105] failed to find an improvement in bone regeneration
with the addition of PRP to Algipore®. Marx suggested that imprecise preparation
methods may cause the inefficiency of PRPs in bone regeneration [104]. As a result,
further research must be conducted into the effects of PRP.
The short term clinical studies conducted by Schopper et al. [100], Ewers et al.
[101] and Poeschl et al. [102] showed the positive effects of mixing Algipore®
with autologous bone debris for maxillary sinus bone augmentation. Despite this,
further research into the long term effects of these implants as well as a control
using Algipore® alone was required. In 2005, Ewers published results of a long-
term clinical study on the use of Algipore® for maxillary sinus grafting [95]. Over
the duration of 14 years, 614 Algipore® implants were grafted in 209 sinus sites of
118 patients following the surgical method reported by Schopper et al. [100]. The
implanted bone graft was composed of Algipore® granules (90%), autologous bone
debris (10%) and either autologous bloodor PRP.Aswith the results of Schopper et al.
[100], new bone tissue was formed within 6 months of grafting, and the Algipore®
graft underwent slight resorption as given by the 14% loss in volume. Implants
that contained PRP were found to improve bone formation, with a 5% increase in
the volume of new bone in comparison to implants with venous blood. Overall,
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only 12% of cases experienced local infection and 27 implants were lost during
the 14-year study, resulting in an implant survival rate of 95.6%. The long-term
study demonstrated the successful use of the calcified marine algae-derived HAp
Algipore® in the clinical application of maxillary sinus grafting.
Algipore® can also be applied as a scaffold for bone tissue engineering applica-
tions due to its chemical similarity to bone and interconnected porosity. Turhani et al.
first showed that Algipore® was capable of supporting the adhesion and prolifera-
tion of osteoblast cells that were isolated from the human mandible bone [106]. Fur-
thermore, it confirmed the biocompatible and osteogenic properties of Algipore® as
shown by previous clinical trials. Afterwards, Malicev et al. successfully constructed
a 3D bone-like tissue by seeding human alveolar osteoblast-like cells into Algipore®
in a rotating bioreactor to allow the even distribution of cells and nutrients [107].
In addition to osteoblast cells, many studies have demonstrated the capacity of
Algipore® to support and differentiate stemcells [108–111]. Itwas first demonstrated
by Turhani et al. [108] who seeded mesenchymal cambial layer precursor cells into
a 3D Algipore® scaffold. These cells underwent osteoblast differentiation within
the algae-derived HAp scaffold and initiated mineralization, showing potential in
producing a 3D bone tissue-engineered implant. Further in vitro studies conducted
by Sollazzo et al. [110] and Girardi et al. [111] usingMSCs also confirm the osteoin-
ductive properties of Algipore® which is crucial in producing a tissue-engineered
bone implant.
Animal studies have shown that the addition ofMSCs and PRP toAlgipore® scaf-
folds improved bone formation and osteogenesis when used for sinus grafting [112]
and mandibular ridge implantation [113] in minipigs. In both studies, a control graft
using Algipore® alone showed signs of bone formation after implantation, but was
significantly slower than MSCs/PRP/Algipore® composites. These studies confirm
that MSCs have osteogenic properties which help enhance bone regeneration, how-
ever further research is required into the contribution ofMSCs and PRP toAlgipore®
scaffolds in bone regeneration before human clinical trials take place. Additionally,
a comparison between traditional Algipore® grafts developed by Schopper et al.
[100] and tissue engineered Algipore® composites should be drawn to see if tissue
engineering can improve bone regeneration.
17.5 Techniques for Analysing Biogenically Derived HAp
Materials
17.5.1 Fourier Transform Infrared Spectroscopy
Fourier transform infrared (FTIR) spectroscopy is a useful tool for the characterisa-
tion of organic and inorganic compounds. This characterisation technique is based
on the molecular vibrations of atoms which arise from the stretching and bending of
molecular bonds [114]. These vibrations have a characteristic frequency that absorbs
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Table 17.6 Characteristic absorption bands for synthetic HAp [16, 115]
Chemical group Absorption band
(cm−1)
Description
OH− 3500 Sharp peak of low intensity
630 Water liberation
Adsorbed H2O 3600–2600 Broad peak of low intensity, may be removed
using heat treatment
1650 Low intensity peak
Adsorbed CO2 2300 Low intensity peak, adsorbed from atmosphere
CO32− 1530 ν3 type A substitution with OH−
1450 ν3 type B substitution with PO43−
870 ν2 vibration of weak intensity
HPO42− 870–880 Medium intensity peak, characteristic of
non-stoichiometric HAp
PO43− 1000–1100 ν3 vibration, large peak of high intensity
960 ν1 vibration, low intensity peak
560–602 ν4 vibration, doublet of medium intensity
460 ν2 vibration
IR radiation at a corresponding energy. For a molecule to be IR active, it must have
a dipole moment caused by the asymmetric vibrations of the bonds.
FTIR spectroscopy is valuable for the characterisation of calciumphosphatemate-
rials, as each phase has characteristic vibrational bands for PO43− ions. FTIR has
the ability to characterise the phase composition of calcium phosphate mixtures and
identify substituted ions in the lattice, namely, CO32− or phase impurities [115].
Additionally, it can examine the crystallinity and purity of the material. Table 17.6
gives the characteristic absorption wavelengths for synthetic HAp and carbonated
apatite.
FTIR spectroscopy has been used in many publications to characterise HAp
derived from biogenically derived CaCO3 [14, 70, 82, 94, 96]. It has also been used to
characterise impurities such as adsorbed carbon dioxide (CO2) from the atmosphere
and residual CaCO3 that did not undergo complete conversion to HAp [70, 82].
Macha et al. used FTIR to identify the intermediate product and phase composition
by characterising sample aliquots throughout conversion [90].
Figure 17.6 displays the FTIR spectrum of H. cylindracea derived HAp. The
synthetic product was characterised as a carbonated apatite due to the presence of
the strong the PO43− band at 1024 cm−1 as well as CO32− vibrational bands between
1400 and 1500 cm−1. The spectrum also display bands contributed by the adsorption
of H2O and CO2. Felício-Fernandes and Laranjeira [14] suggest their removal using
heat treatment up to 650 °C. However, caution must be taken to prevent the porous
microarchitecture from decomposing. The bands in the FTIR spectrum are well
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Fig. 17.6 FTIR spectrum of HAp derived from green algae H. cylindracea (Choi, unpublished
data)
resolved, suggesting that the hydrothermal method developed by Hu et al. produced
HAp of high crystallinity owing to the high temperature and pressure conditions [70].
17.5.2 X-ray Diffraction
X-ray diffraction (XRD) is another characterisation tool used for the analysis of HAp
and other inorganic minerals. In powder XRD, an incident beam is deflected by the
lattice planes in a crystal, forming a diffraction pattern that is characteristic to each
mineral [116]. Like FTIR, powder XRD can be used to characterise HAp, determine
purity and identify additional phase impurities. The lattice parameters of minerals
may also be determined.
For the synthesis of HAp from biogenically derived minerals, a number of studies
used powder XRD analysis to characterise the biogenic mineral, examine the effects
of heat treatment on the phase composition and to characterise the final converted
HAp [14, 70, 82, 84]. Sivakumar et al. [82] and Hu et al. [70] both used power XRD
to characterise the initial CaCO3 polymorph of coral as aragonite, and monitored its
phase transformation to CaO under thermal treatment (Fig. 17.7a).
Powder XRD is also used to characterise HAp by assigning the Miller indices of
the crystal lattice (Fig. 17.7b). Additional peaksmay also identify impurities orminor
phases within the pattern. For example, additional peaks found in the XRD spectrum
of algae-derived HAp by Felício-Fernandes and Laranjeira [14] were attributed to
the formation of minor CaP phases such as OCP and TCP.
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Fig. 17.7 XRD patterns of aGoniopora coral with heat treatment at various temperatures resulting
in the phase transformation of aragonite to calcite then CaO and b coralline HAp with significant
Miller indices (adapted from Hu et al. [70])
Fig. 17.8 TGA traces of
a calcified algae H.




In thermogravimetric analysis (TGA), a material is subjected to high temperatures
to investigate its physical and chemical behaviour [70]. Before the conversion of
biogenic CaCO3, thermal analysis may be conducted on coral or algae to find the
optimal temperature to remove the organic components using thermal treatment
without the decomposition of CaCO3 [70, 82]. For synthetic HAp materials, TGA is
used to determine the appropriate temperature for thermal treatment and the removal
of adsorbed water or carbonate impurities [82]. TGA traces of calcified algae H.
cylindracea as well as H. cylindracea derived-HAp are given in Fig. 17.8, and a
summary of the typical decompositions and phase transformations that occur are
compiled in Table 17.7.
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Table 17.7 Thermal
decomposition of coral,
calcified algae and synthetic







50–140 Removal of adsorbed H2O
150–450 Decomposition and removal of
organics
600–750 Thermal decomposition of




50–250 Removal of absorbed H2O
880–930 Removal of CO32− and OH−
1470 Phase transformation of HAp
to α-TCP (theoretical)
17.5.4 Scanning Electron Microscopy
Scanning electron microscopy (SEM) is a valuable technique for the analysis of the
microarchitecture of biominerals and biogenically derived HAp. An image is formed
by the emission or scattering of electrons from an incident beam that moves across
the surface of the sample [117]. SEM has the capability to magnify beyond what
traditional lightmicroscopes can achieve, as electrons are used instead of light waves.
It allows for microscopic structures such as the unique morphology of minerals and
crystals to be examined [117, 118].
SEM has been used extensively by many authors to examine the porous microar-
chitecture of calcified marine organisms and biogenically derived HAp [14, 69, 70,
84, 88, 94, 96]. The interconnectivity between the pores has also been examined as it
is crucial for bone grafting and bone tissue engineering applications. Pore sizes were
estimated by the authors using SEM analysis, although complementary techniques
such as nitrogen gas adsorption techniques have also been utilised to estimate the
pore size and volume [14, 84].
Acknowledgements The authors with to thank Professor Besim Ben-Nissan of the University of
Technology Sydney and Professor Sophie Cazalbou of the University of Toulouse, France, for their
expert advice together with the members of the Microstructural Analysis Unit of the University of
Technology Sydney.
References
1. LowenstamHA,Weiner S (1989) On biomineralization. Oxford University Press on Demand,
Oxford
2. Weiner S, Dove PM (2003) An overview of biomineralization processes and the problem
of the vital effect. In: Dove PM, DeYoreo JJ, Weiner S (eds) Biomineralization. Reviews in
Mineralogy and Geochemistry, vol 54. Mineralogical Society America, Virginia, pp 1–29
louise.evans@uts.edu.au
17 Calcified Algae for Tissue Engineering 407
3. Mann S (2001) Biomineralization: Principles and Concepts in Bioinorganic Materials Chem-
istry. Oxford University Press, New York
4. Weiner S, Addadi L (1997) Design strategies in mineralized biological materials. J Mater
Chem 7:689–702
5. Addadi L, Raz S, Weiner S (2003) Taking advantage of disorder: Amorphous calcium car-
bonate and its roles in biomineralization. Adv Mater 15:959–970
6. Lowenstam HA (1981) Minerals formed by organisms. Science 211:1126–1131
7. Brandi ML (2009) Microarchitecture, the key to bone quality. Rheumatology 48 Suppl 4:
iv3–8
8. Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3(Suppl
3):S131–S139
9. Thomson BM (1998) Bone. In: Allen LH, Prentice A (eds) Encyclopedia of Human Nutrition
(Second Edition), 2nd edn. Elsevier, Oxford, pp 220–225
10. De Jong W (1926) La substance minerale dans les os. Recl Trav Chim Pays-Bas 45:445–448
11. Terra J, Dourado ER, Eon JG et al (2009) The structure of strontium-doped hydroxyapatite:
an experimental and theoretical study. Phys Chem Chem Phys 11:568–577
12. Weiner S, Wagner HD (1998) The material bone: Structure mechanical function relations.
Annu Rev Mater Res 28:271–298
13. Dorozhkin SV (2007) Calcium orthophosphates. J Mater Sci 42:1061–1095
14. Felicio-Fernandes G, Laranjeira MCM (2000) Calcium phosphate biomaterials from marine
algae. Hydrothermal synthesis and characterisation. Quim Nova 23:441–446
15. LeGeros RZ, Trautz OR, Klein E et al (1969) Two types of carbonate substitution in the apatite
structure. Experientia 25:5–7
16. Ben-Nissan B, Chai C, Evans L (1995) Crystallographic and spectroscopic characterization
and morphology of biogenic and synthetic apatites. In: Wise DL, Trantolo DJ, Altobelli DE
et al (eds) Encyclopedic handbook of biomaterials and bioengineering: part B. Applications.
Marcel Dekker, New York, pp 191–221
17. Combes C, Cazalbou S, Rey C (2016) Apatite biominerals. Minerals. https://doi.org/10.3390/
min6020034
18. LauneyME, Buehler MJ, Ritchie RO (2010) On the mechanistic origins of toughness in bone.
In: Clarke DR, Ruhle M, Zok F (eds) Annual review of materials research, vol 40. Annual
Reviews, California, pp 25–53
19. LeGeros RZ (2008) Calcium phosphate-based osteoinductive materials. Chem Rev
108:4742–4753
20. Thibodeau GA, Patton KT (2013) Structure and function of the body. Elsevier, New York
21. Tang D, Tare RS, Yang LY et al (2016) Biofabrication of bone tissue: approaches, challenges
and translation for bone regeneration. Biomaterials 83:363–382
22. Leach JK, Mooney DJ (2004) Bone engineering by controlled delivery of osteoinductive
molecules and cells. Expert Opin Biol Ther 4:1015–1027
23. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated
with osteoporotic fractures. Osteoporos Int 17:1726–1733
24. Keating JF,McQueenMM(2001) Substitutes for autologous bone graft in orthopaedic trauma.
J Bone Joint Surg Br 83:3–8
25. Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29:2941–2953
26. Finkemeier CG (2002) Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am
84:454–464
27. Oryan A, Alidadi S,Moshiri A et al (2014) Bone regenerative medicine: classic options, novel
strategies, and future directions. J Orthop Surg Res 9:18. https://doi.org/10.1186/1749-799X-
9-18
28. Williams DF (2009) On the nature of biomaterials. Biomaterials 30:5897–5909
louise.evans@uts.edu.au
408 G. Choi and L. A. Evans
29. Park J, Lakes RS (2007) Biomaterials: an Introduction. Springer, New York
30. Sivakumar R (1999) On the relevance and requirements of biomaterials. Bull Mater Sci
22:647–655
31. Dubok VA (2000) Bioceramics - yesterday, today, tomorrow. Powder Metall Met Ceram
39:381–394
32. Langer R, Vacanti JP (1993) Tissue Engineering. Science 260:920–926
33. Nerem RM, Sambanis A (1995) Tissue engineering: from biology to biological substitutes.
Tissue Eng 1:3–13
34. Salgado AJ, Coutinho OP, Reis RL (2004) Bone tissue engineering: state of the art and future
trends. Macromol Biosci 4:743–765
35. Vacanti JP, Langer R (1999) Tissue engineering: the design and fabrication of living replace-
ment devices for surgical reconstruction and transplantation. Lancet 354:SI32-SI34
36. Ramay HR, Zhang M (2004) Biphasic calcium phosphate nanocomposite porous scaffolds
for load-bearing bone tissue engineering. Biomaterials 25:5171–5180
37. Ma L, Gao C, Mao Z et al (2003) Collagen/chitosan porous scaffolds with improved biosta-
bility for skin tissue engineering. Biomaterials 24:4833–4841
38. Mano JF, VazCM,Mendes SC et al (1999) Dynamicmechanical properties of hydroxyapatite-
reinforced and porous starch-based degradable biomaterials. J Mater Sci Mater Med
10:857–862
39. Vacanti JP, Morse MA, Saltzman WM et al (1988) Selective cell transplantation using bioab-
sorbable artificial polymers as matrices. J Pediatr Surg 23:3–9
40. Crane GM, Ishaug SL, Mikos AG (1995) Bone tissue engineering. Nat Med 1:1322–1324
41. Hutmacher DW (2000) Scaffolds in tissue engineering bone and cartilage. Biomaterials
21:2529–2543
42. Gotoh Y, Fujisawa K, Satomura K et al (1995) Osteogenesis by human osteoblastic cells in
diffusion chamber in vivo. Calcif Tissue Int 56:246–251
43. Haynesworth SE, Goshima J, Goldberg VM et al (1992) Characterization of cells with
osteogenic potential from human marrow. Bone 13:81–88
44. Petrakova KV, Tolmacheva AA, Fridenshtein AY (1963) Osteogenesis following transplan-
tation of marrow in diffusion chambers. Bull Exp Biol Med 56:1375–1378
45. Bruder SP, Kurth AA, Shea M et al (1998) Bone regeneration by implantation of purified,
culture-expanded human mesenchymal stem cells. J Orthop Res 16:155–162
46. Rose FR, Oreffo RO (2002) Bone tissue engineering: hope vs hype. Biochem Biophys Res
Commun 292:1–7
47. Reddi AH (1992) Regulation of cartilage and bone differentiation by bone morphogenetic
proteins. Curr Opin Cell Biol 4:850–855
48. Kim TH, Browne F, Upton J et al (1997) Enhanced induction of engineered bone with basic
fibroblast growth factor. Tissue Eng 3:303–308
49. NevinsM,GiannobileWV,McGuireMKet al (2005) Platelet-derived growth factor stimulates
bone fill and rate of attachment level gain: results of a largemulticenter randomized controlled
trial. J Periodontol 76:2205–2215
50. LeGeros RZ, LeGeros JP (2003) Calcium phosphate bioceramics: past, present and future. In:
Ben-Nissan B, Sher D,WalshW (eds) 15th international symposium on ceramics inmedicine,
Sydney, December 2002. Key engineering materials, vol 240–242. Trans Tech Publications,
Zurich-Uetikon, pp 3–10
51. Dimitriou R, Jones E, McGonagle D et al (2011) Bone regeneration: current concepts and
future directions. BMC Med 9:66. https://doi.org/10.1186/1741-7015-9-66
52. Van Lieshout EM, Alt V (2016) Bone graft substitutes and bone morphogenetic proteins for
osteoporotic fractures: what is the evidence? Injury 47:S43–S46
53. Fernández E, Gil FJ, Ginebra MP et al (1999) Calcium phosphate bone cements for clinical
applications. Part II: precipitate formation during setting reactions. J Mater Sci Mater Med
10:177–183
louise.evans@uts.edu.au
17 Calcified Algae for Tissue Engineering 409
54. Dorozhkin SV (2010) Bioceramics of calcium orthophosphates. Biomaterials 31:1465–1485
55. Yuan H, Yang Z, Li Y et al (1998) Osteoinduction by calcium phosphate biomaterials. J Mater
Sci Mater Med 9:723–726
56. Liu JB, Ye XY, Wang H et al (2003) The influence of pH and temperature on the morphology
of hydroxyapatite synthesized by hydrothermal method. Ceram Int 29:629–633
57. Mekmene O, Quillard S, Rouillon T et al (2009) Effects of pH and Ca/P molar ratio on the
quantity and crystalline structure of calcium phosphates obtained from aqueous solutions.
Dairy Sci Technol 89:301–316
58. Jillavenkatesa A, Condrate RA (1998) Sol-gel processing of hydroxyapatite. J Mater Sci
33:4111–4119
59. Santos MH, de Oliveira M, Souza LPdF et al (2004) Synthesis control and characterization
of hydroxyapatite prepared by wet precipitation process. Mater Res 7:625–630
60. Earl JS, Wood DJ, Milne SJ (2006) Hydrothermal synthesis of hydroxyapatite. In: Brown PD,
Baker R, Hamilton B (eds) EMAG/NANO conference on imaging, analysis and fabrication
on the nanoscale, Leeds, August 2005. journal of physics conference series, vol 26. IOP
Publishing Ltd., Bristol, p 268
61. Ramay HR, Zhang M (2003) Preparation of porous hydroxyapatite scaffolds by combination
of the gel-casting and polymer sponge methods. Biomaterials 24:3293–3302
62. Flatley TJ, Lynch KL, Benson M (1983) Tissue response to implants of calcium phosphate
ceramic in the rabbit spine. Clin Orthop Relat Res 179:246–252
63. Hing KA, Annaz B, Saeed S et al (2005) Microporosity enhances bioactivity of synthetic
bone graft substitutes. J Mater Sci Mater Med 16:467–475
64. Mobasherpour I, Heshajin MS, Kazemzadeh A et al (2007) Synthesis of nanocrystalline
hydroxyapatite by using precipitation method. J Alloys Compd 430:330–333
65. Shih WJ, Chen YF, Wang MC et al (2004) Crystal growth and morphology of the nano-sized
hydroxyapatite powders synthesized from CaHPO4·2H2O and CaCO3 by hydrolysis method.
J Cryst Growth 270:211–218
66. Rao RR, Roopa HN, Kannan TS (1997) Solid state synthesis and thermal stability of HAp
and HAp - β-TCP composite ceramic powders. J Mater Sci Mater Med 8:511–518
67. Yeon KC, Wang J, Ng SC (2001) Mechanochemical synthesis of nanocrystalline hydroxya-
patite from CaO and CaHPO4. Biomaterials 22:2705–2712
68. Ghosh SK, Roy SK, Kundu B et al (2011) Synthesis of nano-sized hydroxyapatite powders
through solution combustion route under different reaction conditions. Mater Sci Eng B-Adv
176:14–21
69. Roy DM, Linnehan SK (1974) Hydroxyapatite formed from coral skeletal carbonate by
hydrothermal exchange. Nature 247:220–222
70. Hu J, Russell JJ, Ben-Nissan B et al (2001) Production and analysis of hydroxyapatite from
Australian corals via hydrothermal process. J Mater Sci Lett 20:85–87
71. Vecchio KS, Zhang X, Massie JB et al (2007) Conversion of bulk seashells to biocompatible
hydroxyapatite for bone implants. Acta Biomater 3:910–918
72. Raihana MF, Sopyan I, Hamdi M et al (2008) Novel chemical conversion of eggshell to
hydroxyapatite powder. In: Abu Osman NA, Ibrahim F, Wan Abas WAB et al (eds) 4th Kuala
Lumpur international conference on biomedical engineering, Vols 1 and 2, Kuala Lumpur,
Jun 2008. IFMBE Proceedings, vol 21. Springer, New York, p 333
73. Liu DM (1996) Fabrication and characterization of porous hydroxyapatite granules. Bioma-
terials 17:1955–1957
74. Sepulveda P, Binner JG, Rogero SO et al (2000) Production of porous hydroxyapatite by the
gel-casting of foams and cytotoxic evaluation. J Biomed Mater Res 50:27–34
75. Sopyan I, Kaur J (2009) Preparation and characterization of porous hydroxyapatite through
polymeric sponge method. Ceram Int 35:3161–3168
76. Leukers B, Gülkan H, Irsen SH et al (2005) Hydroxyapatite scaffolds for bone tissue engi-
neering made by 3D printing. J Mater Sci Mater Med 16:1121–1124
louise.evans@uts.edu.au
410 G. Choi and L. A. Evans
77. Fierz FC, Beckmann F, Huser M et al (2008) The morphology of anisotropic 3D-printed
hydroxyapatite scaffolds. Biomaterials 29:3799–3806
78. Cox SC, Thornby JA, Gibbons GJ et al (2015) 3D printing of porous hydroxyapatite scaffolds
intended for use in bone tissue engineering applications. Mater Sci Eng C Mater Biol Appl
47:237–247
79. Sadat-Shojai M, Khorasani MT, Dinpanah-Khoshdargi E et al (2013) Synthesis methods for
nanosized hydroxyapatite with diverse structures. Acta Biomater 9:7591–7621
80. Ivankovic H, Gallego Ferrer G, Tkalcec E et al (2009) Preparation of highly porous hydrox-
yapatite from cuttlefish bone. J Mater Sci Mater Med 20:1039–1046
81. Rodríguez-Lugo V, Hernández JS, Arellano-Jimenez MJ et al (2005) Characterization of
hydroxyapatite by electron microscopy. Microsc Microanal 11:516–523
82. Sivakumar M, Kumar TS, Shantha KL et al (1996) Development of hydroxyapatite derived
from Indian coral. Biomaterials 17:1709–1714
83. Kasperk C, Ewers R (1986) Tierexperimentelle untersuchungen zur einheilungstendenz syn-
thetischer, koralliner und aus Algen gewonnener (phykogener) Hydroxylapatitmaterialien. Z
Zahnärztl Implantol 2:242–248
84. Walsh PJ, Buchanan FJ, Dring M et al (2008) Low-pressure synthesis and characterisation of
hydroxyapatite derived from mineralise red algae. Chem Eng J 137:173–179
85. AllemandD,TambuttéÉ,ZoccolaDet al (2011)Coral calcification, cells to reefs. In:Dubinsky
Z, Stambler N (eds) Coral reefs: an ecosystem in transition. Springer, Dordrecht, pp 119–150
86. Bilan MI, Usov AI (2001) Polysaccharides of calcareous algae and their effect on the calcifi-
cation process. Russ J Bioorgan Chem 27:2–16
87. Green DW, Ben-Nissan B, Yoon KS et al (2017) Natural and synthetic coral biomineralization
for human bone revitalization. Trends Biotechnol 35:43–54
88. Pena J, LeGeros RZ, Rohanizadeh R et al (2000) CaCO3/Ca-P biphasic materials prepared
by microwave processing of natural aragonite and calcite. In: Giannini S, Moroni A (eds)
13th international symposium on ceramic in medicine/symposium on ceramic materials in
orthopaedic surgery: clinical results in the Year 2000, Bologna, November 2000. Key Engi-
neering Materials, vol 192–1. Trans Tech Publications, Zurich-Uetikon, pp 267–270
89. Cegla RNR, Macha IJ, Ben-Nissan B et al (2014) Comparative study of conversion of coral
with ammonium dihydrogen phosphate and orthophosphoric acid to produce calcium phos-
phates. J Aust Ceram Soc 50:154–161
90. Macha IJ, Boonyang U, Cazalbou S et al (2015) Comparative study of coral conversion, Part
2: microstructural evolution of calcium phosphate. J Aust Ceram Soc 51:149–159
91. Guillemin G, Patat JL, Fournie J et al (1987) The use of coral as a bone graft substitute. J
Biomed Mater Res 21:557–567
92. Lough JM (2008) 10th Anniversary Review: a changing climate for coral reefs. J Environ
Monit 10:21–29
93. Wray JL (1977) Calcareous algae. Elsevier Science, New York
94. Kasperk C, Ewers R, Simons B et al (1988) Algae-derived (phycogene) hydroxylapatite. A
comparative histological study. Int J Oral Maxillofac Surg 17:319–324
95. Ewers R (2005) Maxilla sinus grafting with marine algae derived bone forming material: a
clinical report of long-term results. J Oral Maxillofac Surg 63:1712–1723
96. Choi G, Karacan I, Cazalbou S et al (2017) Conversion of calcified algae (Halimeda sp)
and hard coral (Porites sp) to hydroxyapatite. In: Rey C, Combes C, Drouet C (eds), 29th
international symposium on ceramics in medicine, Toulouse, October 2017. Key engineering
materials, vol 758. Trans Tech Publications, Zurich-Uetikon, pp 157–161
97. DennyMW,Gaines SD (eds) (2007) Encyclopedia of Tidepools andRocky Shores. University
of California Press, California
98. Borowitzka MA, Larkum AW (1977) Calcification in the green alga Halimeda. I. An ultra-
structure study of thallus development. J Phycol 13:6–16
99. Tatum H Jr (1986) Maxillary and sinus implant reconstructions. Dent Clin North Am
30:207–229
louise.evans@uts.edu.au
17 Calcified Algae for Tissue Engineering 411
100. Schopper C, Moser D, Wanschitz F et al (1999) Histomorphologic findings on human bone
samples six months after bone augmentation of the maxillary sinus with Algipore. J Long
Term Eff Med Implants 9:203–213
101. Ewers R, Goriwoda W, Schopper C et al (2004) Histologic findings at augmented bone areas
supplied with two different bone substitute materials combined with sinus floor lifting. Report
of one case. Clin Oral Implants Res 15:96–100
102. Poeschl PW, Ziya-Ghazvini F, Schicho K et al (2012) Application of platelet-rich plasma for
enhanced bone regeneration in grafted sinus. J Oral Maxillofac Surg 70:657–664
103. Marx RE, Carlson ER, Eichstaedt RM et al (1998) Platelet-rich plasma: Growth factor
enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:638–646
104. Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg
62:489–496
105. Klongnoi B, Rupprecht S, Kessler P et al (2006) Lack of beneficial effects of platelet-rich
plasma on sinus augmentation using a fluorohydroxyapatite or autogenous bone: an explo-
rative study. J Clin Periodontol 33:500–509
106. Turhani D, Cvikl B,Watzinger E et al (2005) In vitro growth and differentiation of osteoblast-
like cells on hydroxyapatite ceramic granule calcified from red algae. J Oral Maxillofac Surg
63:793–799
107. Malicev E, Marolt D, Kregar Velikonja N et al (2008) Growth and differentiation of alve-
olar bone cells in tissue-engineered constructs and monolayer cultures. Biotechnol Bioeng
100:773–781
108. Turhani D, Watzinger E, Weissenböck M et al (2005) Three-dimensional composites manu-
factured with human mesenchymal cambial layer precursor cells as an alternative for sinus
floor augmentation: an in vitro study. Clin Oral Implants Res 16:417–424
109. WeissenboeckM,SteinE,UndtGet al (2006) Particle size of hydroxyapatite granules calcified
from red algae affects the osteogenic potential of human mesenchymal stem cells in vitro.
Cells Tissues Organs 182:79–88
110. Sollazzo V, Palmieri A, Scapoli L et al (2009) Algipore effects on stem cells derived from
peripheral blood. J Osseointegration 1:78–85
111. Girardi A, Palmieri A, Cura F et al (2012) Effect of Algipore® on bone marrow stem cells:
an in vitro study. Eur J Inflamm 10:59–64
112. Pieri F, Lucarelli E, Corinaldesi G et al (2008) Mesenchymal stem cells and platelet-rich
plasma enhance bone formation in sinus grafting: a histomorphometric study in minipigs. J
Clin Periodontol 35:539–546
113. Pieri F, Lucarelli E, Corinaldesi G et al (2009) Effect of mesenchymal stem cells and platelet-
rich plasma on the healing of standardized bone defects in the alveolar ridge: a comparative
histomorphometric study in minipigs. J Oral Maxillofac Surg 67:265–272
114. Stuart B (2000) Infrared Spectroscopy. Kirk-Othmer Encyclopedia of Chemical Technology.
Wiley, New Jersey
115. Berzina-Cimdina L, Borodajenko N (2012) Research of calcium phosphates using fourier
transform infrared spectroscopy. In: Theophile T (ed) Infrared spectroscopy. IntechOpen,
London. https://doi.org/10.5772/36942
116. Lee M (2016) X-Ray diffraction for materials research: from fundamentals to applications.
Apple Academic Press, New Jersey
117. Sigel A, Sigel H, Sigel RKO (eds) (2008) Biomineralization: from nature to application.
Wiley, Chichester
118. O’Brien P, ImaiH,GreenMet al (eds) (2012)Nanoscience: nanostructures through chemistry.
Royal Society of Chemistry, London
louise.evans@uts.edu.au
412 G. Choi and L. A. Evans
Gina Choi Ms Choi has expertise in calcium phosphate bioce-
ramics and the use of calcified algae for tissue engineering. She
has completed her Honours at the University of Technology Syd-
ney (UTS) on the conversion of calcified algae to hydroxyapatite
for orthopaedic applications. Her most recent publications can
be found in the conference proceedings for Bioceramics 29. She
is currently a PhD candidate at UTS aiming to produced nano-
sized hydroxyapatite coatings on orthopaedic implants using the
sol-gel method under the supervision of Dr. Louise Evans and
Prof. Besim Ben-Nissan.
Louise A. Evans Dr. Louise A. Evans is a Senior Lecturer in
Physical and Inorganic Chemistry at the University of Technol-
ogy Sydney, specializing in Bioinorganic and Medicinal Chem-
istry. She has authored many publications on biomineralization
and bioceramic materials, including a chapter in the Encyclo-
pedic Handbook of Biomaterials and Bioengineering. Her most
recent publications can be found in the conference proceedings
for Bioceramics 29. She is an editor for the Journal of the Aus-
tralian Ceramic Society.
louise.evans@uts.edu.au
